Patient preferences for reducing bowel adverse events following prostate radiotherapy

BACKGROUND: The Extended Prostate Cancer Index Composite (EPIC) instrument is a commonly used patient reported outcome (PRO) tool in prostate cancer clinical trials. Summary scores for EPIC subscales are calculated by averaging patient scores for attributes (e.g., side effects), implying equal weigh...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Mark V., Thayer, Winter Maxwell, Janssen, Ellen, Hoppe, Bradford, Eggleston, Caitlin, Bridges, John F. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343167/
https://www.ncbi.nlm.nih.gov/pubmed/32639983
http://dx.doi.org/10.1371/journal.pone.0235616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343167/
https://www.ncbi.nlm.nih.gov/pubmed/32639983
http://dx.doi.org/10.1371/journal.pone.0235616

Ejemplares similares